pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-527 |
Genomic Coordinates | chr19: 53754018 - 53754102 |
Synonyms | MIRN527, hsa-mir-527, MIR527 |
Description | Homo sapiens miR-527 stem-loop |
Comment | miR-527 cloned in has a 1 nt 3' extension (A), which is incompatible with the genome sequence. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-527 | ||||||||||||||||||||||||||||||||||||
Sequence | 14| CUGCAAAGGGAAGCCCUUUC |33 | ||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||
Experiments | Array-cloned | ||||||||||||||||||||||||||||||||||||
Expression Profile | |||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CDC5L | ||||||||||||||||||||
Synonyms | CDC5, CDC5-LIKE, CEF1, PCDC5RP, dJ319D22.1 | ||||||||||||||||||||
Description | cell division cycle 5 like | ||||||||||||||||||||
Transcript | NM_001253 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CDC5L | |||||||||||||||||||||
3'UTR of CDC5L (miRNA target sites are highlighted) |
>CDC5L|NM_001253|3'UTR 1 AGTACAGTTTATATTCTGTCACAGGATTAATTAATTGCCGGTTTTCATACTCTAGAAGGCTGAAACTGATGTTTATCTTC 81 ATTGACAAATTTACCCACCATCTGTGGTTTTTCAGTTGTTTATTTTAAATGATATCGATCTTACACATTCTGTGTATAAA 161 GACCTTAACTCCACAGGACGGACATTTTAGAGTTTAAATTATTAAGGCTATCATTCTTTTAGTAATGTCATATTTGCAAA 241 CTTTTTTAGTTTTGGCCTTTAATTTAAAAAGCCTAATTTTAAAGTGCTGCCTGTGAGTAACTCTTGAATAAAAACAAAAT 321 ATAAAAAATTGAGAATGTAGCCTTTTGTTTGAAGTAATTAGATACTTAAGAGTGCCTGCAAACCAGCAGCTATGTACTCT 401 GTGTCATATTTAATGAGTAACTCTTGGGTAATCAAAATGGTGATGCAGTATCTTAAACACTTAAGAGGCAGTTCTTTGTG 481 GCTTTGTTAGTTTCAGCAAAGAGTGGTCATTTCTGTATACACTGACAAGTTAGATTAACTTTTTAGTACCTCAAATTTTT 561 TTTTTGTTAATATCACTTTAAAGAAGGTCTCTTGTCTGCCAGCTACTTAAATAATTTATGGGTCAGGGCTTAAAAGATTT 641 AACTTCCTTGCCCCATTATTTTCTTATAAGTATTTTTTGACAAAGGCATTTTAAAAGTTAATTTCAAGAAGGCCATCAAA 721 CTTAAAGCTCTATGTTTAGCCTAAGAAGTCAGTTACATCAGTGTAGAATTTGGGGAATGGATAGAGGTGGAGATATTTAA 801 TTTTATATAATTCATATAAATTGATTTAGTTACAGTATCAGTTGGCTACAAGCTCATTATAGACTAGCAATGTTTTGACA 881 TCACCAAAAACGTTTGCCCAGTCTTAGAATACTAGGGACTATAGGAAGGGAAGGGATTCATTCATTCATTCGATATTGAA 961 TGTATACCCTGTGCCAGAGTCTTAGAGAGAGAACAACAAACAAAATAGGCCTAGTTCTTGTTTAGTAGAGCTTATAGTCT 1041 TTTGAGAATGACAGACAATTAAAATCCAAATGTTTATTTGGTGATTCTTATGTGTCAGACACTTAAGTGTTGGGAGATAA 1121 GCAGTTATTAAGACAGAGTTCTTGCTCTCATGGAGGTGACATTAGTGGGGAGGAGATACTAAGTATGTCCAGGGAAAGTA 1201 TCAGACCATGAGTTTTAGATTCTGTGGAGGAAATTAAAGTAGGGTGATTATGAGATAGTGAATGAGTGGCTATTTTAGAC 1281 TGGACGATCAAAGAGACCTCTTGGAAGGCAGCTATGCTCACCACTATACCACTGCACTGTGCCGCACCGTACCACTATAA 1361 GCTGCACGGCCAAAGAGACCTCTTAAAGAAGTAACATTTAAGATAACATGTGATTGACATTTTAGAATGGGCTATCCTTG 1441 TGAGATTCAAGGAAAGAACATCCTAGGTGGAGTGAATAGCAAACATAAAGCCTCTTTTGTATGTTTGAGGAACAAAAAGG 1521 ACAATGCAGCTAGAGTGTCAAGAATGGCATTTCTGTATATAAGACCTCGTTGTATAGAGCCACATAAATAAGGCTATAAT 1601 AAGGAATTTGGATCTTACTTTAAATATGATAAGAATCGATGAGAAGATCTAAGCAAAGGAATGACATGATCAGATTTGGT 1681 TTTAGAAACATCACTATCTCCTTAGTGTGTAAAATCTCACCAGGCTGGAGATAGGGAAGCCAGTCCAATTAGGAGCCTGA 1761 TGCAGTGATCCAGACAAAAAAATAATAGTGATTCTAACTAGAGTCCAGGTAATAGTAGTGGAGATATGTGGAGAGACATG 1841 ATAGGTATATACTTAATAGTCTTATCAGACGATAAATTGATATTTTCCTGGTGTGTAGTCACTTAATTCAAATACTTTTT 1921 TCAGTAAGTTCTGGGTTTTCTAGGAAAAACTTCAGTATCATCAGTGAATAATGATAGTGTTTCTTCTGATAGTTTTATTT 2001 CACTTTTATTGCATGTTTTGTTATCTGAAATGTTTAGGACAATGTTAACAATAATGATGTTAGACATTTTTTTTTCTTAT 2081 TTTAATGGGAATGTCCATAGTTTTAAGTTTGCTGTTGGGAGTTAGATAGTCTTTATCTGAAAGACAGTGTCTCTCTTTTA 2161 GTTTTTAAAGAGTTTGAATTAGAAATGGCTCTGGAACTTTAAACAGTATACCATTTGGGCATCTATTAAAGCATTCATAT 2241 AATTGTTCTCATTTGATGTTTTGATGAGGTATATTAATAGATTTTCCCACATTAAATCATCTTTGCACTCCTGGAATCAG 2321 GTAGATTAATTTTTAAAAGAAATTTTAAAGGATTTATAGTTTATTTGCACTTTTTGTAGACTTGAATTATATGGATTTAA 2401 AAGTTGATCTAATATTAATAAAGGCTCACTTTGTTTTCAAAATTTGAAGTAATTCACATACTTATAGCCTAAAAAAATCG 2481 GCAGGAATTACAAAATTTCAAAACTGGCACATTGTAAACTGCATATGCATTTGCCAGGTAGTGGTGCCACTTGAAATGGT 2561 GAACAGACACACTGTTATCCTTTGTCAGTATCCTGTAAAGCCCAGGATTCTTTACCAGCACCATACAGCGATTTTGGTGA 2641 CTATTTTAACATTCACACTGAGGCCAGGGGTGGTGAGTCATGCCTGTAATCCTAGCACTTTGGGAGGCCAAGGTGGGAGG 2721 ATCATTTGAGCTCAGGAGTTCAAGATTAGCCTGGGTAACATAGTGAGACCCTGTCTCTATTAAAAAATAATAATAAAAAT 2801 AACATTCACATTGGTATTGTTCACTAAGGTATTGGTTGTTAAGGCATTCATTAAGGTATTGTTAAAACTTGTGTTAAGCA 2881 TGTTAAAGTCTCAGTAACTTTGGGATAGAAATAAAATGTGATAAAAAGCTGAAAGAAACCACCACAAGGGAGAGTCCTTT 2961 TTGAAATATTAGAGACATAATGCTGTCTAATAAAAAACGACATCAAAGAAAAACTACACTACAGTGACTGCAGACTTAAT 3041 GTTGGCCAACCATGCATCCTCCCTAGAAATGCATTTGAATTTGATTTACTAATCTTTTATTTAGGAAATTTACATTTTTA 3121 CATTAGTGAGATTGGTCTTTTGGGCTATTGTACTTTTTTTTTTTTTTTTTTGAGATGGAGTCTTGCTCTCTCACCCAGGC 3201 TGGAGTGCAGTAGTGCAATCTTGGCCCACTGCAACCTCTGCCTCCTGGGCTCGAGTGATTCTCTGCCTCAGCCTTCCAAG 3281 TAGCTGGGACTACAGGCATGTGCCACCGCACCTGGCTAATTTTTGTGTTTTTAGTAGAGATGGGGTTTTGCTATGTTGGC 3361 CAGGCTGGTCTTGAATTCCTGACCTCAGGTGATCCACCTACCTCGGCCTCCCAAAGTGCTAGAATTACAGGTGTGAGCCA 3441 CCATGCCCAGCCTGGTTATTGTATTTTGATATTGGGATTTTGCTAGCTCTCTAAAGTAAATAGGATAACTGTATATCTTT 3521 TTCTGTGCATTAAGCAGTTATAACATGGGAATGATTTGTTCATGAAAGGTTGAAAGTCTGTACTTACAGAACTTTTGAGT 3601 TCACAGTGCTTTCTGGAAATAATTTCTTTATAACTGTCAGTTTCTTTTGTGACTATTATGTTACCTATTTTTAAATTTAA 3681 GCAACTTTAAATTAAAAAAATTGTTTTTAAAAT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | HEK293 | |||||||||
Disease | 988.0 | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_001253 | 3UTR | AUUUUAGAGUUUAAAUUAUUAAGGCUAUCAUUCUUUUAGUAAUGUCAUAUUUGCAAACUUUUUUAGUUUUGGCCUUUAAUUUAAAAAGCCUAAUUUUAAAGUGCUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_001253 | 3UTR | UAUCAUUCUUUUAGUAAUGUCAUAUUUGCAAACUUUUUUAGUUUUGGCCUUUAAUUUAAAAAGCCUAAUUUUAAAGUGCUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_001253 | 3UTR | UUAAAUUAUUAAGGCUAUCAUUCUUUUAGUAAUGUCAUAUUUGCAAACUUUUUUAGUUUUGGCCUUUAAUUUAAAAAGCCUAAUUUUAAAGUGCUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_001253 | 3UTR | UUUAGUAAUGUCAUAUUUGCAAACUUUUUUAGUUUUGGCCUUUAAUUUAAAAAGCCUAAUUUUAAAGUGCUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000371477.3 | 3UTR | AUUUUCCCACAUUAAAUCAUCUUUGCACUCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000371477.3 | 3UTR | AUUUUCCCACAUUAAAUCAUCUUUGCACUCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
147 hsa-miR-527 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT060824 | CEP350 | centrosomal protein 350 | 2 | 2 | ||||||||
MIRT072483 | RAB8B | RAB8B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT076139 | WDR81 | WD repeat domain 81 | 2 | 2 | ||||||||
MIRT076234 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | 2 | 6 | ||||||||
MIRT082393 | HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U like 1 | 2 | 4 | ||||||||
MIRT090337 | SEC61A1 | Sec61 translocon alpha 1 subunit | 2 | 8 | ||||||||
MIRT091944 | ZBTB47 | zinc finger and BTB domain containing 47 | 2 | 6 | ||||||||
MIRT092026 | ABHD5 | abhydrolase domain containing 5 | 2 | 6 | ||||||||
MIRT095382 | UBE2D2 | ubiquitin conjugating enzyme E2 D2 | 2 | 2 | ||||||||
MIRT142425 | TNRC6A | trinucleotide repeat containing 6A | 2 | 6 | ||||||||
MIRT149879 | LDLR | low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT168657 | MAPK14 | mitogen-activated protein kinase 14 | 2 | 2 | ||||||||
MIRT178932 | C11ORF57 | chromosome 11 open reading frame 57 | 2 | 2 | ||||||||
MIRT179071 | PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | 2 | 6 | ||||||||
MIRT193029 | TMOD3 | tropomodulin 3 | 2 | 8 | ||||||||
MIRT195759 | ATMIN | ATM interactor | 2 | 6 | ||||||||
MIRT210002 | LIMD1 | LIM domains containing 1 | 2 | 2 | ||||||||
MIRT211286 | ANKRD50 | ankyrin repeat domain 50 | 2 | 2 | ||||||||
MIRT217609 | NUS1 | NUS1 dehydrodolichyl diphosphate synthase subunit | 2 | 2 | ||||||||
MIRT230981 | PRRG4 | proline rich and Gla domain 4 | 2 | 2 | ||||||||
MIRT248251 | SP1 | Sp1 transcription factor | 5 | 2 | ||||||||
MIRT249363 | BCL2L2-PABPN1 | BCL2L2-PABPN1 readthrough | 2 | 2 | ||||||||
MIRT257800 | CDC5L | cell division cycle 5 like | 2 | 4 | ||||||||
MIRT267985 | UCK2 | uridine-cytidine kinase 2 | 2 | 2 | ||||||||
MIRT301222 | SH3BP4 | SH3 domain binding protein 4 | 2 | 2 | ||||||||
MIRT312574 | G3BP1 | G3BP stress granule assembly factor 1 | 2 | 4 | ||||||||
MIRT315533 | MARCKS | myristoylated alanine rich protein kinase C substrate | 2 | 2 | ||||||||
MIRT343049 | ABHD2 | abhydrolase domain containing 2 | 2 | 2 | ||||||||
MIRT442634 | TBC1D12 | TBC1 domain family member 12 | 2 | 2 | ||||||||
MIRT443424 | MAPT | microtubule associated protein tau | 2 | 2 | ||||||||
MIRT444152 | ZNF701 | zinc finger protein 701 | 2 | 2 | ||||||||
MIRT444500 | ZNF525 | zinc finger protein 525 | 2 | 2 | ||||||||
MIRT445202 | CRYBG3 | crystallin beta-gamma domain containing 3 | 2 | 2 | ||||||||
MIRT447063 | MCC | mutated in colorectal cancers | 2 | 4 | ||||||||
MIRT448125 | CCDC80 | coiled-coil domain containing 80 | 2 | 2 | ||||||||
MIRT460407 | TNFRSF10B | TNF receptor superfamily member 10b | 2 | 4 | ||||||||
MIRT462940 | ZNF800 | zinc finger protein 800 | 2 | 12 | ||||||||
MIRT463575 | ZBTB38 | zinc finger and BTB domain containing 38 | 2 | 2 | ||||||||
MIRT466373 | TGOLN2 | trans-golgi network protein 2 | 2 | 4 | ||||||||
MIRT469270 | RHOB | ras homolog family member B | 2 | 8 | ||||||||
MIRT469300 | RGS16 | regulator of G protein signaling 16 | 2 | 2 | ||||||||
MIRT469803 | RAB14 | RAB14, member RAS oncogene family | 2 | 2 | ||||||||
MIRT470062 | PTGES2 | prostaglandin E synthase 2 | 2 | 2 | ||||||||
MIRT470993 | PITPNA | phosphatidylinositol transfer protein alpha | 2 | 2 | ||||||||
MIRT474950 | KCTD10 | potassium channel tetramerization domain containing 10 | 2 | 4 | ||||||||
MIRT475188 | IMPDH1P11 | inosine monophosphate dehydrogenase 1 pseudogene 11 | 2 | 6 | ||||||||
MIRT475863 | H3F3C | H3 histone family member 3C | 2 | 10 | ||||||||
MIRT475897 | H3F3B | H3 histone family member 3B | 2 | 8 | ||||||||
MIRT481939 | ANKRD11 | ankyrin repeat domain 11 | 2 | 2 | ||||||||
MIRT485555 | FOXQ1 | forkhead box Q1 | 2 | 2 | ||||||||
MIRT491003 | ATF7IP | activating transcription factor 7 interacting protein | 2 | 2 | ||||||||
MIRT492191 | SOCS1 | suppressor of cytokine signaling 1 | 2 | 4 | ||||||||
MIRT493271 | LPP | LIM domain containing preferred translocation partner in lipoma | 2 | 2 | ||||||||
MIRT495272 | NICN1 | nicolin 1 | 2 | 4 | ||||||||
MIRT495674 | PRKD3 | protein kinase D3 | 2 | 2 | ||||||||
MIRT497540 | PPTC7 | PTC7 protein phosphatase homolog | 2 | 2 | ||||||||
MIRT500397 | ZMAT3 | zinc finger matrin-type 3 | 2 | 8 | ||||||||
MIRT500483 | ZBTB4 | zinc finger and BTB domain containing 4 | 2 | 6 | ||||||||
MIRT500585 | UQCRFS1 | ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 | 2 | 4 | ||||||||
MIRT500634 | TUBB2A | tubulin beta 2A class IIa | 2 | 8 | ||||||||
MIRT501640 | PHLDA3 | pleckstrin homology like domain family A member 3 | 2 | 2 | ||||||||
MIRT501768 | NRBF2 | nuclear receptor binding factor 2 | 2 | 6 | ||||||||
MIRT503665 | SLC46A1 | solute carrier family 46 member 1 | 2 | 2 | ||||||||
MIRT504321 | ASGR2 | asialoglycoprotein receptor 2 | 2 | 6 | ||||||||
MIRT505176 | VMA21 | VMA21, vacuolar ATPase assembly factor | 2 | 4 | ||||||||
MIRT506340 | NUP54 | nucleoporin 54 | 2 | 6 | ||||||||
MIRT506434 | NACC2 | NACC family member 2 | 2 | 2 | ||||||||
MIRT506666 | LZIC | leucine zipper and CTNNBIP1 domain containing | 2 | 4 | ||||||||
MIRT510973 | PFN2 | profilin 2 | 2 | 6 | ||||||||
MIRT511141 | MRPL17 | mitochondrial ribosomal protein L17 | 2 | 8 | ||||||||
MIRT512600 | EFCAB1 | EF-hand calcium binding domain 1 | 2 | 4 | ||||||||
MIRT521036 | SLC30A4 | solute carrier family 30 member 4 | 2 | 2 | ||||||||
MIRT525735 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT526750 | GAS7 | growth arrest specific 7 | 2 | 2 | ||||||||
MIRT526902 | ZNF772 | zinc finger protein 772 | 2 | 6 | ||||||||
MIRT527345 | FAM69C | family with sequence similarity 69 member C | 2 | 2 | ||||||||
MIRT531900 | GLP2R | glucagon like peptide 2 receptor | 2 | 2 | ||||||||
MIRT532366 | LINC00598 | long intergenic non-protein coding RNA 598 | 2 | 2 | ||||||||
MIRT534252 | SLC12A7 | solute carrier family 12 member 7 | 2 | 2 | ||||||||
MIRT534743 | RAVER2 | ribonucleoprotein, PTB binding 2 | 2 | 4 | ||||||||
MIRT535340 | PFN1 | profilin 1 | 2 | 2 | ||||||||
MIRT535971 | MESDC1 | talin rod domain containing 1 | 2 | 2 | ||||||||
MIRT536507 | KCTD15 | potassium channel tetramerization domain containing 15 | 2 | 2 | ||||||||
MIRT536884 | HIC2 | HIC ZBTB transcriptional repressor 2 | 2 | 2 | ||||||||
MIRT537038 | GRAMD4 | GRAM domain containing 4 | 2 | 2 | ||||||||
MIRT537424 | FBXL7 | F-box and leucine rich repeat protein 7 | 2 | 2 | ||||||||
MIRT544577 | AP5Z1 | adaptor related protein complex 5 zeta 1 subunit | 2 | 4 | ||||||||
MIRT546422 | SNX5 | sorting nexin 5 | 2 | 2 | ||||||||
MIRT546753 | RLIM | ring finger protein, LIM domain interacting | 2 | 2 | ||||||||
MIRT547984 | HCFC2 | host cell factor C2 | 2 | 4 | ||||||||
MIRT548407 | ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | 2 | 2 | ||||||||
MIRT549444 | ACSL4 | acyl-CoA synthetase long chain family member 4 | 2 | 2 | ||||||||
MIRT549670 | ZNF598 | zinc finger protein 598 | 2 | 2 | ||||||||
MIRT550525 | MYZAP | myocardial zonula adherens protein | 2 | 2 | ||||||||
MIRT551213 | CIDEC | cell death inducing DFFA like effector c | 2 | 2 | ||||||||
MIRT552306 | ZXDA | zinc finger, X-linked, duplicated A | 2 | 4 | ||||||||
MIRT552429 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT553197 | UBE2A | ubiquitin conjugating enzyme E2 A | 2 | 2 | ||||||||
MIRT553336 | TRPC3 | transient receptor potential cation channel subfamily C member 3 | 2 | 4 | ||||||||
MIRT554806 | REL | REL proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT555179 | PRUNE2 | prune homolog 2 | 2 | 2 | ||||||||
MIRT556150 | MECP2 | methyl-CpG binding protein 2 | 2 | 2 | ||||||||
MIRT557862 | FGFR1OP | FGFR1 oncogene partner | 2 | 2 | ||||||||
MIRT562084 | KIAA0895 | KIAA0895 | 2 | 2 | ||||||||
MIRT563331 | RPLP0 | ribosomal protein lateral stalk subunit P0 | 2 | 2 | ||||||||
MIRT565308 | TMEM41A | transmembrane protein 41A | 2 | 2 | ||||||||
MIRT566134 | RACGAP1 | Rac GTPase activating protein 1 | 2 | 2 | ||||||||
MIRT567023 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT567241 | HSPA13 | heat shock protein family A (Hsp70) member 13 | 2 | 2 | ||||||||
MIRT568559 | AKAP10 | A-kinase anchoring protein 10 | 2 | 2 | ||||||||
MIRT570682 | FZD5 | frizzled class receptor 5 | 2 | 2 | ||||||||
MIRT572220 | BTN3A3 | butyrophilin subfamily 3 member A3 | 2 | 2 | ||||||||
MIRT573304 | AKR7A2 | aldo-keto reductase family 7 member A2 | 2 | 2 | ||||||||
MIRT575741 | Zfp618 | zinc finger protein 618 | 1 | 1 | ||||||||
MIRT613460 | B3GNT6 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 | 2 | 2 | ||||||||
MIRT614733 | STAT5A | signal transducer and activator of transcription 5A | 2 | 2 | ||||||||
MIRT615117 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT623237 | MLLT6 | MLLT6, PHD finger containing | 2 | 2 | ||||||||
MIRT623486 | KCTD11 | potassium channel tetramerization domain containing 11 | 2 | 2 | ||||||||
MIRT623989 | FAM104A | family with sequence similarity 104 member A | 2 | 2 | ||||||||
MIRT624010 | EPHB1 | EPH receptor B1 | 2 | 2 | ||||||||
MIRT626277 | PEX26 | peroxisomal biogenesis factor 26 | 2 | 2 | ||||||||
MIRT631415 | CRLS1 | cardiolipin synthase 1 | 2 | 4 | ||||||||
MIRT641134 | ZBTB33 | zinc finger and BTB domain containing 33 | 2 | 2 | ||||||||
MIRT647829 | RAB23 | RAB23, member RAS oncogene family | 2 | 2 | ||||||||
MIRT649063 | HSD17B12 | hydroxysteroid 17-beta dehydrogenase 12 | 2 | 2 | ||||||||
MIRT650283 | PYCARD | PYD and CARD domain containing | 2 | 2 | ||||||||
MIRT651511 | WNT4 | Wnt family member 4 | 2 | 2 | ||||||||
MIRT651851 | UNC5D | unc-5 netrin receptor D | 2 | 2 | ||||||||
MIRT652214 | TRIM33 | tripartite motif containing 33 | 2 | 2 | ||||||||
MIRT654703 | PRRC2B | proline rich coiled-coil 2B | 2 | 2 | ||||||||
MIRT656792 | KNTC1 | kinetochore associated 1 | 2 | 2 | ||||||||
MIRT656925 | KIAA1462 | junctional cadherin 5 associated | 2 | 2 | ||||||||
MIRT659157 | DCTN5 | dynactin subunit 5 | 2 | 2 | ||||||||
MIRT663085 | METTL10 | EEF1A lysine methyltransferase 2 | 2 | 2 | ||||||||
MIRT676043 | AUTS8 | Autism, susceptibility to, 8 | 2 | 2 | ||||||||
MIRT680128 | ADRBK2 | G protein-coupled receptor kinase 3 | 2 | 2 | ||||||||
MIRT689530 | KIAA0513 | KIAA0513 | 2 | 2 | ||||||||
MIRT691473 | FOXRED2 | FAD dependent oxidoreductase domain containing 2 | 2 | 2 | ||||||||
MIRT692504 | SPIN4 | spindlin family member 4 | 2 | 2 | ||||||||
MIRT702404 | KITLG | KIT ligand | 2 | 2 | ||||||||
MIRT704531 | CNEP1R1 | CTD nuclear envelope phosphatase 1 regulatory subunit 1 | 2 | 2 | ||||||||
MIRT714230 | ARMC10 | armadillo repeat containing 10 | 2 | 2 | ||||||||
MIRT718760 | HOOK3 | hook microtubule tethering protein 3 | 2 | 2 | ||||||||
MIRT725421 | HNRNPA3 | heterogeneous nuclear ribonucleoprotein A3 | 2 | 2 | ||||||||
MIRT732824 | PCNA | proliferating cell nuclear antigen | 3 | 0 | ||||||||
MIRT734767 | GPC3 | glypican 3 | 2 | 0 |